PEABODY, MASS. - Analogic Corporation (NASDAQ: ALOG) has launched LIFEGARD I non-invasive patient monitor for continuous monitoring as well as for single spot-check measurements of vital signs. One of the most versatile patient monitors in its class, the LIFEGARD I is successor to the Company's popular LIFEGARD patient monitor.

The LIFEGARD I, the latest in a series of non-invasive patient monitors from Analogic, measures ECG, HR, SpO2, NIBP, and Predictive Temperature (optional), and has network communication capability with the LIFEGARD Vue Central Nurses' Station.

Designed primarily for continuous patient monitoring in low-acuity-care areas with full patient alarm capability, the LIFEGARD I can also be easily employed as a stat- or spot-check monitor for use either in the physician's office or from patient to patient within the ward. When using "spot-check" mode, all audible alarms are automatically disabled, a new patient identification is assigned for each new set of measurements, and previous patient data can be deleted easily.
Its integral battery, with 4 to 8 hours of operating time, combined with its light weight (less than 5 lbs.), compact "go anywhere" housing, and ergonomic handle, make the LIFEGARD I an ideal choice for transport and for first-responders. Its easy-to-use, intuitive user interface is consistent with the other LIFEGARD monitors.

Dan Webster, General Manager of Analogic's Life Care Systems Division, noted, "The LIFEGARD I is a significant addition to our growing LIFEGARD family of non-invasive patient monitors. The portable LIFEGARD I brings a new level of versatility to patient monitoring by allowing clinicians to utilize it almost anywhere in the hospital, including general care, ED, triage and recovery areas, or in non-acute environments such as freestanding clinics and physicians' offices."

Analogic's LIFEGARD family of non-invasive patient monitors also includes LIFEGARD II, a uniquely powerful monitor that measures ECG, HR, SpO2, NIBP, Continual NIBP, Temperature, Respiration, end tidal CO2, Non-Invasive Cardiac Output via impedance cardiography, and 17 derived hemodynamic parameters; LIFEGARD ICG, a standalone Non-Invasive Cardiac Output and hemodynamic status monitor; and the LIFEGARD Vue Central Nurses' Station. Additional models with expanded capabilities that have already received U.S. Food & Drug Administration (FDA) clearance will be launched over the next 12 months. For more information on LIFEGARD I or any other monitors in the LIFEGARD family, go to www.analogic.com/lifegard, or call 800-599-7769.

Analogic offers a complete line of accessories for all LIFEGARD family products as well as reusable and disposable supplies. Accessories and supplies may be purchased through your local dealer or at Analogic's LIFEGARD e-store: www.analogic.com/lifegardstore

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), and Patient Monitoring.

More Voices